Investment
Features
FeesSafety
Academy
More
Pluang+

Compare JPMorgan Diversified Return International Eqty ETF (JPIN) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance

JPMorgan Diversified Return International Eqty ETFTrade
Oruka Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

JPMorgan Diversified Return International Eqty ETF vs Oruka Therapeutics Inc. Common Stock — how do they compare? JPMorgan Diversified Return International Eqty ETF trades at $73 (market cap $382.97M), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B). The key difference: Oruka Therapeutics Inc. Common Stock is far larger — about 13.5× JPMorgan Diversified Return International Eqty ETF's market cap, and Oruka Therapeutics Inc. Common Stock is more actively traded (490,798 versus 1,797). Which is the better fit depends on your goals — on Pluang, investors hold JPMorgan Diversified Return International Eqty ETF for 121 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.

JPINORKA
Market Cap
$382.97M$5.18B
Volume
1,797490,798
52-Week High
$77.80$113.08
52-Week Low
$65.86$26.19
Typical Hold Time
121 Days0 Days
Sector
—Health
Enterprise Value
—$4.31B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

JPMorgan Diversified Return International Eqty ETF

JPIN, the JPMorgan Diversified Return International Equity ETF, trades at $73.52, up 0.65% today. Technical indicators are overwhelmingly bearish, with moving averages and oscillators signaling selling pressure, though the RSI suggests potential oversold conditions. The ETF provides broad exposure to international large-cap value stocks. A dividend of $0.51 is scheduled for payment in September 2026.

The outlook is cautious due to strong bearish technical signals. The primary opportunity lies in the ETF's international diversification and value focus, but risks include global market volatility and the current negative momentum. Investors should weigh the oversold RSI against the dominant sell signals.

Oruka Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JPIN
100% Buy0% Sell
Avg holding period · 121 Days
ORKA
100% Buy0% Sell
Avg holding period · 0 Days

About JPMorgan Diversified Return International Eqty ETF

The fund will invest at least 80% of its assets in securities included in the underlying index. The underlying index is comprised of equity securities across developed global markets (excluding North America) selected to represent a diversified set of factor characteristics.

Read more on JPIN →

About Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.

Read more on ORKA →